Press release
Alzheimer's Disease Diagnosis Market Forecasted to Expand at 11.19% CAGR, Reaching US$ 213,374.50 Million by 2032
Alzheimer's Disease Diagnostics Market was valued at US$ 92,190.10 million in 2024 and is projected to grow at a CAGR of 11.19% from 2025 to 2032, driven by the rising burden of neurodegenerative conditions and increasing demand for early and accurate diagnosis.The market is witnessing consistent expansion due to the growing global prevalence of Alzheimer's disease and other forms of dementia, along with a rapidly aging population. Currently, over 57 million individuals worldwide are living with dementia, and nearly 10 million new cases are reported annually. These figures are expected to climb significantly in the coming decades as life expectancy increases.
The steady increase in the elderly population worldwide, combined with a growing number of Alzheimer's disease cases, is significantly boosting the demand for advanced diagnostic technologies. Early and precise detection is essential for better disease management, appropriate therapeutic intervention, and enhanced patient outcomes.
According to data released by the European Brain Council in January 2025, nearly 7 million individuals in Europe are currently living with Alzheimer's disease. This number is expected to rise sharply, potentially reaching around 14 million by 2030, largely due to demographic ageing trends.
Enjoy a free sample before purchasing the full report.@ https://www.analystviewmarketinsights.com/request_sample/AV4692
GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Abbott Laboratories
Roche Diagnostics
Siemens Healthineers
GE HealthCare
Fujirebio
Biogen
Quanterix
C2N Diagnostics
Thermo Fisher Scientific
Danaher Corporation
Others
GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032
Early-Onset Alzheimer's Disease
Late-Onset Alzheimer's Disease
Others
GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY DIAGNOSTIC TECHNIQUE ANALYSIS, 2019 - 2032
Neuroimaging
Biomarker Tests
Genetic Testing
Cognitive Tests
Others
GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032
Hospitals & Clinics
Diagnostic Laboratories
Research Institutes
Others
Alzheimer's Disease Diagnostics Market - Competitive Landscape
The Alzheimer's disease diagnostics market is characterized by moderate competition, with prominent companies prioritizing innovation, biomarker research, and strategic partnerships to enhance their competitive edge. Market participants are heavily investing in the development of advanced blood-based assays, improved neuroimaging technologies, and AI-driven diagnostic platforms to enable earlier and more accurate detection of the disease.
Full report with toc @ https://www.analystviewmarketinsights.com/reports/report-highlight-alzheimers-disease-diagnostics-market
Navigate more industry studies
Synthetic Biology Market @ https://www.analystviewmarketinsights.com/reports/report-highlight-synthetic-biology-market
Smart TV Market @ https://www.analystviewmarketinsights.com/reports/report-highlight-smart-tv-market
Respiratory Humidifying Equipment Market @ https://www.analystviewmarketinsights.com/reports/report-highlight-respiratory-humidifying-equipment-market
NEXT-Generation Military Radar Systems Market @ https://www.analystviewmarketinsights.com/reports/report-highlight-next-generation-military-radar-systems-market
About Us:
AnalystView Market Insights serves as a strategic catalyst for global enterprises, specializing in high-fidelity market intelligence and growth-oriented consulting. By bridging the gap between raw data and decisive action, the firm empowers organizations to thrive within ever-evolving economic environments. Their methodology combines rigorous analysis with a proactive mindset across high-impact verticals-including Healthcare, Chemicals, Food & Beverages, and Electronics-ensuring clients do not merely react to the market but actively lead it. Through a comprehensive suite of syndicated reports, bespoke consulting, and predictive forecasting, AnalystView provides the clarity needed to transform industry disruptions into sustainable competitive advantages.
Contact Us:
Mr. Mayank Agrawal
AnalystView Market Insights
📞 U.S. Toll Free: +1 (458) 215-0449
📞 India: +91 86980 55292
📧 Email: inquiry@analystviewmarketinsights.com
🌐 Website: www.analystviewmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimer's Disease Diagnosis Market Forecasted to Expand at 11.19% CAGR, Reaching US$ 213,374.50 Million by 2032 here
News-ID: 4403517 • Views: …
More Releases from AnalystView Market Insights
Pressure Sensor Market to Reach Nearly US$ 28.8 Billion by 2032 at 4.2% CAGR | M …
Market Overview
The global pressure sensor market is witnessing strong growth momentum driven by rapid industrial automation, expanding automotive electronics integration, and increasing adoption of smart monitoring systems across industries. Pressure sensors are critical components used to measure and monitor gas or liquid pressure in applications ranging from manufacturing equipment and oil & gas pipelines to medical devices and consumer electronics.
Pressure Sensor Market size was valued at US$ 20,786.43 Million in…
Agriculture Sensor Market to Reach Nearly US$ 6.24 Billion by 2032 with 12.01% C …
Market Overview
Agriculture Sensor Market size was valued at US$ 2,521.45 Million in 2024 and is projected to reach approximately US$ 6,238 Million by 2032, expanding at a CAGR of 12.01% from 2025 to 2032. The Agriculture Sensor Market is undergoing rapid transformation as digital technologies reshape traditional farming practices. Agriculture sensors are intelligent monitoring devices designed to collect real-time data related to soil conditions, crop health, climate variables, and livestock…
DevSecOps Market Set for Accelerated Growth at 12.98% CAGR
DevSecOps Market Overview
DevSecOps Market size was valued at US$ 8,901.98 Million in 2024 and is projected to reach approximately US$ 23,640 Million by 2032, expanding at a CAGR of 12.98% from 2025 to 2032. The DevSecOps market represents one of the fastest-evolving segments within the broader cybersecurity and software development landscape. DevSecOps - short for Development, Security, and Operations - integrates security practices directly into the DevOps lifecycle, ensuring that…
Display Market to Reach US$ 214.6 Billion by 2032, Growing at 5.87% CAGR
Display Market size was valued at US$ 136,001.8 Million in 2024 and is projected to reach approximately US$ 214,610 Million by 2032, expanding at a CAGR of 5.87% from 2025 to 2032. The Display Market represents one of the most dynamic and innovation-driven segments within the global electronics and semiconductor ecosystem. Displays serve as the primary interface between users and digital devices, enabling visual communication across smartphones, televisions, laptops, tablets,…
More Releases for Alzheimer
Alzheimer Therapeutics Market Breakthrough Innovations and Increasing Treatment …
The Alzheimer Therapeutics Market is rapidly evolving as disease-modifying therapies, early-stage diagnostic tools, and biomarker-driven treatment approaches reshape global management of Alzheimer's disease (AD). As one of the most prevalent neurodegenerative conditions, Alzheimer's affects millions of older adults worldwide. With recent regulatory approvals of anti-amyloid monoclonal antibodies, enhanced imaging technology, and increased R&D investment, the market is experiencing unprecedented momentum.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51928
Key Takeaways
• Disease-modifying…
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
